Kowa Files For Japan Approval Of Glaucoma, Ocular Hypertension Drug
This article was originally published in PharmAsia News
Executive Summary
Kowa has filed for approval of its Rho kinase inhibiting glaucoma and ocular hypertension drug K-115 (ripasudil hydrochloride hydrate) on Oct. 10,